1-2

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients.

Post : Research Associate / Scientist

Department : Regulatory Affairs 
Division : APL RC I
Location : Bachupally

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

A pharmaceutical generics business company. HPRA Approved (April 2021) facility for veterinary generic medicines. Parent entity based in Ireland. Indian corporate office located at Gurgaon and R&D Center is at Greater Noida. Manufacturing facility based at SEZ Pithampur, Indore.

Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka, India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Amneal is a global essential medicines company powered by a robust U.S. generics business. Amneal is a growing branded business with deepening portfolios in institutional injectables, biosimilars and select international markets including India.

Walk in Drive for Injectable Plant

Established in 2012, Honour Lab Limited is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) & Intermediates. Honour Lab Limited has 5 state-of-the-art manufacturing facilities located in Hyderabad, Visakhapatnam and Pune which are approved by USFDA, TGA, MFDS, MOT, PMDA and PICS. Backed by a strong R&D with 100+ top notch scientists, the company excels at developing high-quality products which meet the demands of the rapidly growing global drug markets.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.